Company profile

Alphabiome.ai company profile

Alphabiome uses artificial intelligence to decode the genetic complexity of the human microbiome and identify biomarkers that predict treatment efficacy. Alphabiome’s mission is to unlock the full potential of the microbiome to transform how diseases are understood, diagnosed, and treated . Its proprietary technology enables large-scale, reference-free analysis of microbial DNA – converting trillions of untapped genetic fragments into actionable insights for drug development, clinical decision-making, and precision medicine.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2022-03-01

Headquarters

Headquarters
Kador, Riau, Indonesia
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$8M
Last funding
Seed / $8M / 2025-05-06
Last equity funding
Seed / $8M
Investors
2
Lead investors
2
Founders
2

Founders and investors

Founders

Alex PentlandYaniv Altshuler

Lead investors

AIX VenturesNew Era Capital Partners

Investors

AIX VenturesNew Era Capital Partners

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.